Dasatinib-Induced Colitis: Risk of misdiagnosis of inflammatory bowel disease. A case report and review of the literature

• मुख्य लेखकों: Graziana Arborea (लेखक), Anna Maria Valentini (लेखक), Stefania Marangi (लेखक), Nicoletta Labarile LT (लेखक), Maria Teresa Savino (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications, 2023-05-24.
• विषय: Case Report
• ऑनलाइन पहुंच: Connect to this object online.

<p>Dasatinib is a potent tyrosine kinase inhibitor, in disease states associated with BCR/ABL 1, approved in 2006 for chronic myeloid leukemia treatment. This agent has been shown to exhibit broad off-target kinase inhibition and immunomodulating properties. These effects may be responsible fo...